US 12,290,407 B2
System and method of monitoring a life-threating medical situation based on an ejection-fraction measurement
Lazaro Eduardo Hernandez, Cooper City, FL (US)
Filed by Lazaro Eduardo Hernandez, Cooper City, FL (US)
Filed on Sep. 20, 2023, as Appl. No. 18/471,150.
Application 18/471,150 is a continuation in part of application No. 17/935,505, filed on Sep. 26, 2022, granted, now 11,957,505.
Application 17/935,505 is a continuation in part of application No. 17/210,013, filed on Mar. 23, 2021, granted, now 11,457,889, issued on Oct. 4, 2022.
Claims priority of provisional application 63/141,465, filed on Jan. 25, 2021.
Prior Publication US 2024/0008856 A1, Jan. 11, 2024
Int. Cl. A61B 8/00 (2006.01); A61B 8/08 (2006.01)
CPC A61B 8/5223 (2013.01) [A61B 8/0883 (2013.01); A61B 8/4236 (2013.01); A61B 8/4455 (2013.01); A61B 8/463 (2013.01); A61B 8/465 (2013.01); A61B 8/488 (2013.01); A61B 2560/02 (2013.01); A61B 2560/06 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A method of monitoring a life-threating medical situation based on a real-time ejection-fraction measurement, the method comprising the steps of:
(A) providing a medical monitoring system, wherein the medical monitoring system includes an ultrasound transducer, a bedside monitor, a system central processing unit (CPU), and wherein a normal ejection-fraction range is managed by the system CPU, wherein the system CPU is a monitor CPU of the bedside monitor, and wherein the ultrasound transducer includes a flat body, a transducer head, a footprint, and a piezoelectric crystal arrangement, and wherein the flat body includes an outer body surface and an inner body surface, and wherein the transducer head is hingedly connected to the flat body with a projected angle set between 120 degrees to 180 degrees, and wherein the footprint and the piezoelectric crystal arrangement are integrated into the transducer head;
(B) attaching the ultrasound transducer onto a specific skin portion of a patient, wherein the specific skin portion is positioned adjacent to a heart of the patient;
(C) sensing a continuous echocardiographic data with the ultrasound transducer;
(D) relaying the continuous echocardiographic data from the ultrasound transducer to the system CPU;
deriving the real-time ejection-fraction measurement from the continuous echocardiographic data with the system CPU;
and outputting a life-threatening situation alert with the medical monitoring system, wherein the real-time ejection-fraction measurement is outside of the normal ejection-fraction range.